As people’s demand for maintaining youth and health increases, the global anti-aging market continues to grow. Consumers are also evolving from focusing on specific product categories to focusing on the core functional ingredients in products, and even various indicators such as the purity, efficacy data, and green safety of the ingredients.
Recently, our enzyme products were invited to participate in the recording of Shenzhen TV’s “Super Launch Conference” program, where we had the honor of showcasing the company’s technological leadership , industrialization strength , and flagship product portfolio in the field of synthetic biology to the public on an official stage .
1. Founder of Bosein
Pro-Xylane, one of the most popular ingredients in the functional skincare market, has been a global bestseller for over 20 years. It boasts excellent moisturizing and firming effects, helping to delay skin aging. The product structure of Pro-Xylane is similar to that of omeprazole, a blockbuster gastrointestinal drug in the pharmaceutical field. Omeprazole has two configurations: the S configuration and the R configuration, with the later-developed S configuration being more effective than the R configuration.
Why didn’t the original research company produce the S- configuration of Bosein? The enzyme product development team traced the reasons and discovered that around 2000, synthetic biology technology was still in its infancy and couldn’t be applied to industrial practice. With the technology at the time, mass production of the S -configuration of Bosein could only be achieved through chemical synthesis. However, chemical methods were uneconomical and generated a large amount of waste, which seriously contradicted the original research company’s green and environmentally friendly philosophy. Therefore, they had to settle for using a mixed-configuration Bosein.
By the time enzyme products were introduced in 2017, the industry had made significant technological advancements. Enzymes offer mild reaction conditions, high catalytic efficiency, and good selectivity, enabling reactions that are difficult to achieve using chemical methods at room temperature and pressure, making them a green and environmentally friendly synthetic technology. Since the S configuration is superior, finding an enzyme that synthesizes only the S configuration would allow for the mass production of pure S- configuration Boseine.
Through breakthroughs in enzyme screening and modification, the company has taken the lead in achieving large-scale biological production of pure S- configuration Bosein. A large amount of third-party research data shows that the activity of the finished enzyme S -configuration Bosein is superior to that of the R- configuration, and it has a better effect on stimulating the synthesis of glycosaminoglycans and collagen. It also has advantages in safety, stability and permeability . It has gained the recognition of hundreds of customers, and the company has thus become the leading brand in the sales of S- configuration Bosein .
2. Leader in Smegglutinin biosynthesis
Smegglutide became a global bestseller last year. It is a blood sugar-lowering drug primarily used for adults with type 2 diabetes. It belongs to the GLP-1 receptor agonist class, and GLP-1 is a short-peptide hormone naturally present in everyone’s body. When L cells in the gastrointestinal tract sense food intake, they stimulate the secretion of this short-peptide hormone. This hormone can increase insulin secretion and decrease glucagon secretion, thus controlling postprandial blood sugar. It can also slow gastric emptying, preventing overeating.
Smegglutide is a drug developed by mimicking short peptide hormones found in the human body. In the current market, apart from the original research companies, most raw material manufacturers synthesize it using chemical methods, which not only limits production capacity but also results in high production costs.
The enzyme product utilizes synthetic biology technology, relying on the company’s R&D strength and industrialization capabilities, to achieve the first large-scale bio-based production of Smegglutide in China, significantly reducing the manufacturing cost of raw materials and making it a healthy choice for consumers.
Some online sources claim that Smegglutide is a highly effective and safe weight-loss miracle product, even promising “slimming down while lying down,” attracting many slightly overweight individuals. However, it’s important to remind consumers that Smegglutide is a prescription drug. Always consult a doctor before use to determine the appropriate dosage based on your individual health condition. Only by using Smegglutide rationally and effectively, combined with a healthy lifestyle, can you truly achieve your health goals.
3. Pioneers in peptide biosynthesis
After nearly seven years of development and accumulation, our enzyme products have successfully completed the research, mass production, and commercialization of several distinctive products, including Smegglutinin, S- Pro-Xylane, Blue Copper Peptide, Ergothioneine, Ectoin, NMN, Glutathione, and Carnosine . These products are mainly composed of active ingredients such as peptides, sugars, proteins, and nucleic acids, and can be applied in many fields such as functional skincare, biomedicine, nutrition and health, and pet health.
The company has successfully built a leading “Green Bio-manufacturing Platform” integrating R&D and industrialization, and established a core technology system covering the discovery, improvement, and application of new enzymes. In addition to a research team of hundreds of people specializing in enzyme screening, modification, and application, we have also established an artificial intelligence subsidiary in the UK to use AI technology and biocomputing to assist in the virtual screening of biological components such as enzymes.
In terms of production, our two major production bases, the Gansu base with a capacity of tens of tons and the Zhuhai base with a capacity of hundreds of tons , have both been put into operation. At the same time, the company is also preparing for more and larger industrial bases.
4. Anti-aging technology for allOver the past few years, our enzyme products have provided comprehensive professional support to over a thousand brands and manufacturers in the fields of functional skincare, biopharmaceuticals, and nutritional health, covering the entire chain from raw materials to formulation application, efficacy, and safety evaluation. Starting in the second half of 2023, we began conducting complete safety assessment tests on all our raw materials, becoming one of the first green active ingredient companies in China to provide complete safety assessment reports .
With the increasing popularity and deepening of ESG principles and sustainable development, consumers are paying more attention to the greenness and sustainability of raw materials while focusing on product safety and efficacy. Enzyme Products is committed to becoming a global leader in green active ingredients, using synthetic biotechnology to enable consumers to purchase better, safer, and greener health products, providing them with more choices for a high-quality, healthy lifestyle.
As a synthetic biology company, we hope to use the power of technology to do more for people’s health.
5. Regarding finished enzyme products
Enzyme Products is committed to becoming a global leader in green active ingredients, employing next-generation synthetic biology technologies to focus on the green production of active ingredients such as peptides, proteins, sugars, and nucleic acids. Leveraging over 20 years of research and industry experience accumulated by its founding team, the company has established a leading multidisciplinary technology platform in China. It has now achieved mass production of dozens of green active ingredients, including Smegglutinin, Telborpeptide, S -Pros-Xylane, NAD+, Blue Copper Peptide, HMOs, and various peptides. It has cumulatively provided high-quality green active ingredients to over a thousand well-known companies in the fields of biopharmaceuticals , functional skincare, nutritional health, and pet and animal health .
After seven years of rapid development, the company has achieved a leading position among global companies of its kind in terms of R&D investment, scale, and output. It has applied for more than 100 invention patents and has received more than ten national and local titles, including National Specialized and Innovative Small Giant, National High-tech Enterprise, Shenzhen Specialized and Innovative Small and Medium Enterprise, Shenzhen Potential Unicorn Enterprise, Shenzhen Postdoctoral Innovation Practice Base, Shenzhen Top 30 Medical and Health Innovation Team, Zhuhai Innovation and Entrepreneurship Team, and Gansu Specialized and Innovative Small and Medium Enterprise. In 2022, it was selected as one of Shenzhen’s Top 100 High-Growth Enterprises (ranked first among unlisted biotech companies), and in 2023, it was selected as a Harvard Business Review High-Energy Innovation Team.